Core Scientific, Inc.CORZNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
0.00%
↓ 100% below average
Average (16q)
20.88%
Historical baseline
Range
High:342.31%
Low:-100.00%
Volatility
2118.0%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | -100.00% |
| Q4 2024 | 76.56% |
| Q3 2024 | 30.68% |
| Q2 2024 | 20.84% |
| Q1 2024 | -4.10% |
| Q4 2023 | -16.73% |
| Q3 2023 | 37.38% |
| Q2 2023 | 15.90% |
| Q1 2023 | -46.74% |
| Q4 2022 | -57.09% |
| Q3 2022 | -58.09% |
| Q2 2022 | 342.31% |
| Q1 2022 | -2.99% |
| Q4 2021 | 117.09% |
| Q3 2021 | 0.00% |